Journal of Mind and Medical Sciences
Volume 3

Issue 2

Article 11

2016

Gastrointestinal stromal tumor (GIST) of the Treitz’s angle– a very
rare cause of high bowel obstruction
Mădălina Elena Tobă
Titu Maiorescu University of Bucharest, Faculty of Medicine, madalinatoba@yahoo.co.uk

Dan Florin Ungureanu
Titu Maiorescu University of Bucharest, Faculty of Medicine, fdungureanu@gmail.com

Lota Corina Georgescu
Bucharest Oncology Institute, lota_corina@yhoo.com

Traian Pătraşcu
Carol Davila University of Medicine and Pharmacy, Faculty of Medicine, patrascutraian@gmail.com

Follow this and additional works at: https://scholar.valpo.edu/jmms
Part of the Digestive System Diseases Commons, Neoplasms Commons, and the Surgery Commons

Recommended Citation
Tobă, Mădălina Elena; Ungureanu, Dan Florin; Georgescu, Lota Corina; and Pătraşcu, Traian (2016)
"Gastrointestinal stromal tumor (GIST) of the Treitz’s angle– a very rare cause of high bowel obstruction,"
Journal of Mind and Medical Sciences: Vol. 3: Iss. 2, Article 11.
Available at: https://scholar.valpo.edu/jmms/vol3/iss2/11

This Case Presentation is brought to you for free and open access by ValpoScholar. It has been accepted for
inclusion in Journal of Mind and Medical Sciences by an authorized administrator of ValpoScholar. For more
information, please contact a ValpoScholar staff member at scholar@valpo.edu.

Gastrointestinal stromal tumor (GIST) of the Treitz’s angle– a very rare cause of
high bowel obstruction
Cover Page Footnote
This material is part of a larger retrospective study of a Ph.D. thesis, currently under development by
Madalina Elena TOBA, Univ. assistant, MD, Ph.D. Candidate at the Carol Davila University of Medicine and
Pharmacy, with Univ. Professor, MD, Ph.D., Traian PATRASCU as thesis coordinator. The thesis has the
following title: “ALGORITHMS FOR DIAGNOSIS AND TREATMENT IN STROMAL GASTROINTESTINAL
TUMORS (GISTs)”. Also, the authors declare no conflicts of interest and received no funding for
developing this publication.

This case presentation is available in Journal of Mind and Medical Sciences: https://scholar.valpo.edu/jmms/vol3/
iss2/11

J Mind Med Sci. 2016; 3(2): 194- 202. Case Presentation

Gastrointestinal stromal tumor (GIST) of the Treitz’s angle–
a very rare cause of high bowel obstruction
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Abstract

Gastrointestinal stromal tumors (GIST) are somewhat rare gastrointestinal tumors approximately 1% to 3% incidence, but they are the most common mesenchymal neoplasms
of the gastrointestinal tract. GISTs are usually found in the stomach or small intestine but
can occur anywhere within the gastrointestinal tract, even in extremely uncommon locations
like duodeno-jejunal flexure. Only 3% – 5% of GISTs are located in the duodenum and
tumors occurring in the angle of Treitz are even rarer, most published studies being case
reports. These tumors have a size ranging from small lesions to large masses and can cause
digestive bleeding or high bowel obstruction.
This paper is a case presentation illustrating an emergency situation involving a high
bowel obstruction caused by a small tumor with an unusual location in the Treitz’s angle. A
large percentage of duodenal GISTs are localized in the third and fourth part of the
duodenum and may not be found through standard upper endoscopy; only the barium study
of the upper gastrointestinal tract highlights the obstruction point. Preoperative diagnosis is
difficult but non-invasive imaging techniques like ultrasonography and computed
tomography of the abdomen can be helpful. Recently, targeted therapy with inhibitors of
tyrosine kinase receptors (IMATINIB) has been introduced for the management of
advanced and metastatic tumors. In our opinion the surgical resection with curative intent is
the treatment of choice.

Keywords: Gastrointestinal stromal tumor (GIST), Treitz’s angle, high bowel
Obstruction, digestive bleeding, immunohistochemistry, CD 117
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syndrome or Crohn’s disease) (6). Patients with

Introduction
The first authors that coined the term GIST
were Mazur and Clarke in 1983, referring to distinct
mesenchymal

tumors

that

lack

features

duodenal GIST have the symptoms such as
abdominal

pain,

iron-deficiency

anemia,

gastrointestinal bleeding, or vomiting caused by an

characteristic of smooth muscles differentiation (1). obstruction. A tumor of the angle of Treitz may also
In 1998, Kindblom et al. demonstrated that the be an incidental finding during clinical
actual origin’s cell of these tumors is a pluripotent examination.
mesenchymal stem cell programmed to differentiate
into interstitial cells of Cajal, the gastrointestinal
tract "pacemaker cells" - the cells responsible for
initiating and coordinating gastrointestinal motility
(2). The most important development that made
GIST a unique clinical entity was the discovery of
c-kit proto-oncogene in these tumors by Hirota and

Limited surgical resection or pancreaticoduodenectomy is the treatment of choice (7). Most
tumors located at the angle of Treitz are
gastrointestinal stromal tumors (GISTs) and only a
few are adenocarcinomas.
From our broad experience with tumors

been located at the level of Treitz angle (10 cases
demonstrated as a very specific and sensitive reported so far), we selected this one for detailed
analysis as it manifested as a GIST during
marker, with about 95% of GISTs express c-KIT.
colleagues

in

1998

(3).

C-KIT

has

Usually, GISTs appear in middle age,
affecting males and females equally. They rarely
occur in children or young adults, but when they do,
an association with neurofibromatosis and Carney's
triad

(gastric

stromal

tumor,

extra

immunochemistry exams. Although the surgical
approach was optimal and the general outcome
positive, this type of tumor poses challenges for the
surgeon and raises several interesting points for
discussion.

adrenal

paraganglioma and pulmonary chordoma) has been Material and Methods
This paper presents the case of a female
noted (4).
patient, G.S., 54 years old, who was admitted to our
A GIST can be located anywhere in the

clinic, Witting Clinical Hospital, General Surgery

gastrointestinal tract. Small intestinal tumors occur

Department, for persistent abdominal pain in the
in 20-30% of digestive tract tumors; duodenal epigastrium and left hypochondrium associated
tumors occur less than 5%. Tumors occurring in the with asthenia, pallor of skin, weight loss of about 5
angle of Treitz are even rarer, with most published kg.; symptoms occurred within the past 6 months.
studies being case reports (5). Most such cases These symptoms were accompanied in the last 16
occur sporadically, but some may occur in the hours by nausea and vomiting. The patient’s history
context of a familial syndrome (Peutz-Jeghers was negative for alcohol, tobacco, or illicit drug use
195
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and her family history was unremarkable. The

Blood tests revealed a hemorrhagic anemia

patient had no surgical history and was under (Hgb = 8,2 gm/dl, Hct = 29,9% and MCV, MCH,
treatment

for

hypertension

(maximum

value MCHC in low levels), iron deficiency (serum iron =
195/110 mmHg) with Bisoprololum 10mg (1 tablet 36 mcg/dl), positive fecal occult blood test, slightly
daily), Quinalaprilum 10 mg (2 tablets daily), and altered kidney function (BUN = 60 mg/dl,
Acetylsalicylic Acidum 75 mg (1 tablet daily).
Creatinine = 1,34 mg/dl); other blood tests were
within normal limits, including the levels of tumor
markers (CEA, CA 19–9, α-fetoprotein).
After nasogastric tube positioning, the upper
endoscopy revealed dilated hypotonic stomach and
duodenum with lesions of erosive gastritis and
Figure 1. Barium study of the upper gastrointestinal
tract filling defect of the fourth portion of the duodenum
with dilated stomach and duodenum proximal to the site
of obstruction and gastroesophageal reflux without
radiological signs of hiatal hernia.

duodenitis. Using barium study of the upper
gastrointestinal tract, we found a filling defect of
the fourth portion of the duodenum, with dilated

On physical examination the patient was stomach and duodenum proximal to the site of
found under weight, pale and with tachycardia obstruction; we also found gastroesophageal reflux
(pulse rate – 110/min, blood pressure – 130/85 without radiological signs of hiatal hernia (Figure
mmHg; the belly was mobile with respiratory 1). Ultrasonography and CT scan showed no
movements, painful spontaneous and on palpation metastases.
in epigastrium, without palpable mass; auscultation

Surgery was recommended after correcting

revealed normal bowel sounds and the bowel was the anemia and electrolyte balance. A midline
preserved. Rectal exam was normal.

laparotomy was chosen, revealing a tumor of about
2 cm in diameter, with a circumscribed mass shape
was found at the fourth part of the duodenum,
developed mostly in the lumen, with extensive
mesenteric fibrosis in the near of the Treitz’ angle
and important distension of the stomach and
duodenum.

No

macroscopic

involvement

of

regional lymph nodes or liver and no direct invasion
Figure 2. Intraoperative image 2 cm. diameter
circumscribed mass in the fourth part of duodenum,
developed in the lumen, with important distension of the
stomachand duodenum

of the pancreas had occurred (Figure 2).
The tumor was resected with 5 cm of
uninvolved duodenal margins, and an end-to-side
196
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anastomosis was performed between the descending
duodenum and the proximal jejunum (Figure 3).
Access to the third and fourth part of the duodenum
was gained by complete mobilization of the Treitz’s
angle from the left side of the proximal jejunum to
the right side of the angle, by cutting the ligament
of Treitz.
The

histological

examination

of

the

specimen demonstrated an intramural small tumor -

Figure 3. Intraoperative image after resection of the

2 cm in diameter with intraluminal growth and

tumor, the end-to-side anastomosis between
descending duodenum and the proximal jejunum

the

obstruction. The final diagnosis was a high-grade
ulcerated GIST with classic spindle cells, clear Discussion
The maximum incidence places GIST at
resection margins and no lymph node invasion
(Figure 4). Mitotic activity was 12/50 on HPF gastric level (50% - 70%) and small intestine (20%(High-Power Fields). Ki67 proliferation marker 30%), being followed by colon and rectal locations
labels 10% of the nuclei (Figure 5).
Immunohistochemistry was positive for
CD117/c-kit and CD34 immunomarkers (Figure 6)
and negative for desmin, vimentin, musclespecificactin, smooth muscle actin, S-100protein
and neuron-specific enolase.

(10%), epi-ploon and mesenteric areas, esophagus
(5%) and retroperitoneal space (5%). As already
pointed out, duodenal tumors occur less than 5%,
and tumors occurring in the angle of Treitz are even
rarer (5).
The epidemiology of GISTs cannot be
completely estimated. The average age of patients

The patient’s postoperative course passed with GISTs is 53 years and only 5% are under the
without any problems. An oncologist colleague age of 30. Duodenal GISTs commonly involve the
started adjuvant treatment with inhibitors of second part of the duodenum followed by the third,
tyrosine kinase receptors – IMATINIBMESYLATE fourth, and first part (8).
Duodenal GISTs are relatively small in size,
400mg once daily for 2 years.
with the median reported to be 4 cm in contrast to
The patient is disease-free after a 1.5 year
the median of gastric and small intestinal GISTs of
follow-up. A recent barium gastrointestinal follow
6 to 7 cm, respectively. Duodenal GISTs that are
up study demonstrated a widely patent anastomosis detected early when they are smaller are amenable
with a normal mucosal pattern between the to relatively minor resection or excisional surgery.
proximal duodenum and jejunum (Figure 7) and They may also have a favorable prognosis in
ultrasoudsonography and CT scan do not highlight comparison to GISTs from other sites of the
pathological lesions.

gastrointestinal tract (8).
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Patients with duodenal GIST have the
symptoms that may include abdominal pain, irondeficiency

anemia,

gastrointestinal

bleeding,

obstructive jaundice, palpable mass or vomiting
caused by an obstruction. In our case, a high bowel
obstruction was caused by the tumor with location
in the Treitz’s angle, but we note a previous six
Figure 4. Microscopic finding bundles of spindle cells
with elongated nuclei and significant mitotic activity (H &
E staining; 100x optical magnification)

month evolution of gastrointestinal bleeding and
iron-deficiency anemia. A tumor of the angle of
Treitz may also be an incidental finding.
A large percentage of duodenal GISTs are
localized in the third and fourth part of the
duodenum and may not be found through standard
upper endoscopy. Intraluminal growth is visualized
on barium radiography as a distinct, smooth filling
defect; ulceration or depression at the peak of the
protrusion can be observed. Endoscopic ultrasound
is helpful when the tumors are submucosal or arise
from an intramural or extramural structure (9, 10).
CT scan and MRI are the optimal imaging tests for

Figure 5. Microscopic finding exhibiting a positive
immunohistochemistry for Ki 67 (Ki67 staining; 40x
optical magnification)

description of the primary lesion, the local
extension, and metastasis.
Surgical treatment represents one of the
most efficient approaches to cure a GIST. The
possibility of a real, life-saving resection gives
these types of tumors a positive overall prognosis.
This trend for a positive outcome remains even
when there is local spread to adjacent organs if a
true radical and complex excision is performed
during the initial surgery. However, this is not the
case for a GIST that has already become metastatic;

Figure 6. Microscopic finding immunohistochemistry

a different clinical outcome should be expected,

exhibiting a strong positive for CD117 (CD117 staining;
optical magnification of 40x).

with a very low survival rate.
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tumor and its local spread to the nearby organs,
avoidance of the peritoneal pollution with tumor
debris, and minimizing the lymphatic resection, since
these tumors do not take the lymphatic route for a
wide metastatic spread.
All GISTs are considered as malignant, even
the intramural with a diameter of less than 2 cm,
and therefore should be resected; in this regard, a
laparoscopic approach is allowed.
The evolution of GIST tumors has been
estimated,

based

on

studies

considering

a

combination of clinical and anatomo-pathological
factors. Strong evidence demonstrates these tumors
are influenced by their location within the digestive
Figure 7. Follow-up barium study of the upper
gastrointestinal tract widely patent anastomosis with a
normal mucosal pattern betweenthe proximal duodenum
and jejunum

tract. Thus, the tumors located at the level of the
small bowel tend to develop a malignant action
more frequently than gastric tumors, and tumors

The tumor relapse rate or the possibility of a developing at the level of the colon or rectum tend
metastatic behavior occurs in about 50% of cases, to display a more metastatic behavior. Some
even if radical excision of the primary tumor is studies, based on a large scale clinical research,
performed; the responsible factors include: tumor point out some markers for a severe prognosis:
fracture during intraoperative manipulation or aneuploidy (proven by the means of fluxperforming a palliative resection or even a sub- cytometry): size of the tumor, coagulation based
standard so-called extended resection, with remnant necrosis, a low score for Ki67 marker and
margins positive for tumoral traces.

peritoneal spreading during the initial surgery (11,

Primary tumor resection allows for a 12).
survival rate of about one year from the main

At the time of their first diagnosis, almost

surgery, and the main sites for tumoral relapse are 25%-30% of all GISTs are malignant as the feature
the liver, the great omentum and the peritoneal secondary metastasis (most often at the level of
surface. The basic rules of classic oncologic surgery liver) or are spread locally. As malignant evolution
should be applied with the utmost attention, such as is unpredictable and benign development is less
tumoral-free remnant margins, a monolith-like likely, the rest of the tumors have been approached
dissection that takes into the same block the primary with different levels of medical aggression.
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In surgical practice, when we discuss the Conclusions
risk of aggressivity, we take into consideration both

Based on our experience, the reasons behind

the size of the tumor and its mitotic index. the rarity of gastrointestinal stromal tumors could
reside in one or all the following: the high speed of
Therefore we now recognize GISTs that are rated as
the digestive transit, the alkaline pH of the small
very low, low, intermediate, or high risk of
bowel, the reduced bacterial population diversity
aggression, based on their potential of developing
and concentration in the small bowel, less
metastases and relapse (13).
aggressive liquid content of the small bowel, high
Benign characteristics of these tumors are: a
concentration of IgA at this level, with a proven
size less than 5 cm of the tumor, a low mitotic index local protective role and, finally, a high content of
of less than 5 mitoses per 20 High Power Field, benzipren-hidroxylaze
enzyme
Nikon technology, a 40x optical magnification, a anticarcinogenetic potential.
10x objective. The mitotic index is interpreted in

with

high

Surgical resection is the primary treatment

close relationship with the cellular type, nuclear for GIST tumors and the only therapy offering a
modifications, and cellularity.

chance of cure, although there is evidence that

Targeted therapy with inhibitors of tyrosine IMATINIB-based therapy has significant potential.
GISTs located at the level of duodenum
kinase receptors (IMATINIB) has been introduced
appear slow-growing and exhibit a limited
for the management of advanced and metastatic
propensity for both metastatic and local spread;
tumors. Primary resistance of these tumors to the
such favorable biologic characteristics mandate an
Imatinib™ is noted at about 5%, and secondary
aggressive surgical approach to this disease, aimed
resistance develops due to some second-stage
at complete tumor excision with negative histologic
mutations of the tirozin-kinazic receptor (14-16); a
margins.
possible way to work around this problem is to
The location and histology of the tumors
increase the 24 hr dosage or the surgical
permitted
a
pancreas-preserving
segmental
intervention to remove the remnant tumor. Some
duodenectomy, a real benefit for a tumor located at
authors cite partial clinical resistance with a the level of Treitz’s angle, the operative approach
remission of a tumor clone while other tumors yet chosen allowing the patient to develop very well in
develop.
the postoperative stage with a general favorable
Sometimes simple resection with a free outcome in the long term.
margin of about 2 cm provides the edge necessary

One of the goals of this paper was to

to defeat the malignant evolution of a case and showcase an extremely rare tumor located at an
provide full recovery with no relapse at the 5-year extremely rare level of the small bowel that could
mark.

well end up in a diagnosis trap. Also, the rarity of
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these cases, their evolutive particularities, survival References
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